On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness

Anand, 2010, C-reactive protein is a bystander of cardiovascular disease, Eur Heart J, 31, 2092, 10.1093/eurheartj/ehq242 Androulakis, 2011, Stefanadis. Inflammation in hypertension: current therapeutic approaches, Curr Pharm Des, 17, 4121, 10.2174/138161211798764753 Barter, 2011, HDL-C: role as a risk modifier, Atheroscler Suppl, 12, 267, 10.1016/S1567-5688(11)70885-6 Bedi, 2010, Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal–medial thickness: a meta-analysis of randomized controlled trials, J Cardiovasc Pharmacol Ther, 15, 268, 10.1177/1074248410369110 Cheng, 2002, A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors, Cardiovasc Res, 54, 528, 10.1016/S0008-6363(01)00551-X Choy, 2009, Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions, Ann Rheum Dis, 68, 460, 10.1136/ard.2008.101964 De Bacquer, 2006, The prevalence of concomitant hypertension and hypercholesterolaemia in the general population, Int J Cardiol, 110, 217, 10.1016/j.ijcard.2005.08.037 2010, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet, 375, 132, 10.1016/S0140-6736(09)61717-7 Enomoto, 2011, LDL-C/HDL-C ratio predicts carotid intima-media thickness progression better than HDL-C or LDL-C alone, J Lipids, 549137 Expert Panel, 2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486 Gokulakrishnan, 2008, Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES-31), Clin Biochem, 41, 480, 10.1016/j.clinbiochem.2008.01.030 Lemieux, 2001, Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity, Arterioscler Thromb Vasc Biol, 21, 961, 10.1161/01.ATV.21.6.961 Lorenz, 2007, High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study, Stroke, 38, 1774, 10.1161/STROKEAHA.106.476135 Masoura, 2011, Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins A systematic review and meta-analysis, Atherosclerosis, 214, 129, 10.1016/j.atherosclerosis.2010.10.008 Mills, 2011, Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials, QJM, 104, 109, 10.1093/qjmed/hcq165 Navab, 2011, HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms, Nat Rev Cardiol, 8, 222, 10.1038/nrcardio.2010.222 O'Leary, 2010, Imaging of atherosclerosis: carotid intima-media thickness, Eur Heart J, 31, 1682, 10.1093/eurheartj/ehq185 Paffen, 2006, C-reactive protein in atherosclerosis: a causal factor?, Cardiovasc Res, 71, 30, 10.1016/j.cardiores.2006.03.004 Paramsothy, 2010, Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 56, 1034, 10.1016/j.jacc.2010.01.073 Paul, 2005, A proatherogenic role for C-reactive protein in vivo, Curr Opin Lipidol, 16, 512, 10.1097/01.mol.0000180164.70077.a7 Pearson, 2003, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 Pirro, 2001, (2001) Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men, Arch Intern Med, 161, 2474, 10.1001/archinte.161.20.2474 Pirro, 2003, Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias, Metabolism, 52, 432, 10.1053/meta.2003.50072 Ridker, 2007, C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus, J Am Coll Cardiol, 49, 2129, 10.1016/j.jacc.2007.02.052 Ridker, 2007, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score, JAMA, 297, 611, 10.1001/jama.297.6.611 Ridker, 2008, C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men, Circulation, 118, 2243, 10.1161/CIRCULATIONAHA.108.814251 Schillaci, 2006, C-reactive protein in hypertension: clinical significance and predictive value, Nutr Metab Cardiovasc Dis, 16, 500, 10.1016/j.numecd.2006.05.001 Schillaci, 2003, Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures, J Hypertens, 21, 1841, 10.1097/00004872-200310000-00010 Shah, 2011, Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?, Rev Cardiovasc Med, 12, e55, 10.3909/ricm0565 Sitzer, 2002, C-reactive protein and carotid intimal medial thickness in a community population, J Cardiovasc Risk, 9, 97, 10.1097/00043798-200204000-00005 St-Pierre, 2005, Inflammatory markers and long-term risk of ischemic heart disease in men: a 13-year follow-up of the Quebec Cardiovascular Study, Atherosclerosis, 182, 315, 10.1016/j.atherosclerosis.2005.02.009 Su, 2001, Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan, Stroke, 32, 2265, 10.1161/str.32.10.2265 Thakore, 2007, Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study), Am J Cardiol, 99, 1598, 10.1016/j.amjcard.2007.01.036 Tropeano, 2011, Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials, Fundam Clin Pharmacol, 25, 395, 10.1111/j.1472-8206.2010.00832.x Vaudo, 2000, Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension, Am J Hypertens, 13, 324, 10.1016/S0895-7061(99)00229-0 Vaudo, 2007, Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries, Metabolism, 56, 541, 10.1016/j.metabol.2006.11.016